Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Hair and nails contain stable RNA, useful for personalized medicine and screening.

FR-1 reduces skin scarring and promotes healing without harmful effects.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Bupropion SR may help treat trichotillomania.

SPARC likely aids in tissue remodeling during the hair cycle, not in starting new hair growth phases.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

TAp63 and NRF2 work together to manage oxidative stress, preventing premature aging and aiding skin functions.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Granulation tissue-derived cells can aid wound healing and serve as an alternative source of stem cells for tissue repair.

ITK inhibitors may effectively treat alopecia areata.

Mutations in certain receptors can cause diseases and offer new treatment options.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

A specific group of early-stage melanocytes is reduced in vitiligo-affected skin, which may explain treatment resistance.

Precise objectives can improve student achievement in health education.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Loss of TET2 increases the risk of skin and oral cancer.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Laser therapy on human skin affects the HERC6 gene and related genes, influencing many cell processes and requiring careful safety measures.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.